The Purdue Cancer Center is a basic cancer center which functions to develop a multidisciplinary program for experimental cancer research that focuses on the elucidation of the biological and biochemical events involved in cell transformation as the basis for new approaches to the prevention, diagnosis and therapy of cancer. The objectives of the Purdue Cancer Center are to organize and expand existing programs in cancer research at Purdue University, to stimulate new research in selected areas, to contribute to advanced training in cancer research, and to develop interactions among Purdue cancer researchers and cancer researchers at other Universities, hospitals and research laboratories within the State of Indiana to facilitate the translation of basic research findings to the treatment and prevention of human cancer. The Cancer Center conducts research in five major program areas: Experimental Therapeutics and Diagnostics, Structural Biology, Cell Growth and Differentiation, Veterinary Oncology and Epidemiology, and Carcinogenesis. All Cancer Center program areas are supported by individual and group research grants. To facilitate these research programs the Cancer Center provides shared resources through the Cancer Center Support Grant, which include: Cytotoxicity Testing, Antibody Production, Mass Spectrometry, Peptide Synthesis, and Flow Cytometry. In addition, the Cancer Center Support Grant provides development funds to recruit new faculty to enhance the collaborative cancer research of the program areas and helps to provide aid in planning and evaluation. The Center also provides small grants to stimulate cancer research through programs funded by the Indiana Elks and the American Cancer Society. This request is for the continuation of partial Cancer Center Support Grant support for the administration of the Center, planning and evaluation, the recruitment of new cancer research faculty and the shared resources as well as for additional support to help initiate other essential shared resources for Media Preparation, NMR, DNA Sequencing, Animal Resources and a Transgenic Animal Resource, and for a pilot program for development of translational research. The Cancer Center Support Grant has already resulted in the development of a broad basic research program directed to understanding the causes of cancer the growth of cancer cells, and the development of new approaches to treating cancer. The requested funds will allow the Purdue Cancer Center to continue and to carry out this research and to rapidly translate these findings to clinical applications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA023168-20S1
Application #
2790771
Study Section
Cancer Center Support Review Committee (CCS)
Program Officer
Mccormick, Patricia
Project Start
1994-06-21
Project End
2003-06-30
Budget Start
1998-05-08
Budget End
1999-06-30
Support Year
20
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Purdue University
Department
Type
Organized Research Units
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Ghosh, Arun K; Ghosh, Koena; Brindisi, Margherita et al. (2018) Design, synthesis, X-ray studies, and biological evaluation of novel BACE1 inhibitors with bicyclic isoxazoline carboxamides as the P3 ligand. Bioorg Med Chem Lett 28:2605-2610
Thompson, Taylor J; Han, Bumsoo (2018) Analysis of adhesion kinetics of cancer cells on inflamed endothelium using a microfluidic platform. Biomicrofluidics 12:042215
Alpsoy, Aktan; Dykhuizen, Emily C (2018) Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes. J Biol Chem 293:3892-3903
Kumari, Rashmi; Silic, Martin R; Jones-Hall, Yava L et al. (2018) Identification of RECK as an evolutionarily conserved tumor suppressor gene for zebrafish malignant peripheral nerve sheath tumors. Oncotarget 9:23494-23504
Larocque, Elizabeth A; Naganna, N; Opoku-Temeng, Clement et al. (2018) Alkynylnicotinamide-Based Compounds as ABL1 Inhibitors with Potent Activities against Drug-Resistant CML Harboring ABL1(T315I) Mutant Kinase. ChemMedChem 13:1172-1180
Poh, Scott; Chelvam, Venkatesh; Ayala-López, Wilfredo et al. (2018) Selective liposome targeting of folate receptor positive immune cells in inflammatory diseases. Nanomedicine 14:1033-1043
VerHeul, Ross; Sweet, Craig; Thompson, David H (2018) Rapid and simple purification of elastin-like polypeptides directly from whole cells and cell lysates by organic solvent extraction. Biomater Sci 6:863-876
AlAbdi, Lama; He, Ming; Yang, Qianyi et al. (2018) The transcription factor Vezf1 represses the expression of the antiangiogenic factor Cited2 in endothelial cells. J Biol Chem 293:11109-11118
Coleman, Rachel A; Trader, Darci J (2018) A Sensitive High-Throughput Screening Method for Identifying Small Molecule Stimulators of the Core Particle of the Proteasome. Curr Protoc Chem Biol 10:e52
Liu, Yunhua; Xu, Hanchen; Van der Jeught, Kevin et al. (2018) Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer. J Clin Invest 128:2951-2965

Showing the most recent 10 out of 436 publications